Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function

Abstract

This study provides Class IV evidence that for boys with DMD, vamorolone demonstrated possible efficacy compared to a natural history cohort of glucocorticoid-naive patients and appeared to be tolerated.